Biote Corp. Class A Common Stock (BTMD)
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Biote Corp. Class A Common Stock (BTMD) is listed on Nasdaq, where it has traded since May 27, 2022.
- Listed On
- Nasdaq
- Listed Since
- May 27, 2022
- Employees
- 223
- Market Cap
- $35M
About Biote Corp. Class A Common Stock
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 70 institutions reported holding BTMD, with 13.2 million shares worth $24.9 million in aggregate. The largest reported holder was 325 Capital, with 4.5 million shares worth $8.6 million. Of the 5 largest holders listed below, 1 opened a new position in BTMD, 2 reduced their positions and 2 held their positions unchanged during the quarter.
| Institution | Shares | Value | Quarter change |
|---|---|---|---|
| 325 Capital | 4,548,127 | $9M | Unchanged |
| Bandera Partners | 2,065,482 | $4M | Unchanged |
| Vanguard | 1,251,597 | $2M | Reduced 1.98% |
| Acadian Asset Management | 625,390 | $1M | Reduced 10.38% |
| Millennium Management | 436,088 | $824K | New position |
Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.
Frequently asked questions
What is BTMD?
Biote Corp. Class A Common Stock (BTMD) is listed on Nasdaq, where it has traded since May 27, 2022.
Who are the largest institutional holders of BTMD?
In 13F filings for the quarter ended June 30, 2026, the largest reported holders of BTMD were 325 Capital, Bandera Partners and Vanguard.
How many institutions own BTMD?
70 institutions reported a position in BTMD for the quarter ended June 30, 2026, worth $24.9 million in total.
Did institutions buy or sell BTMD last quarter?
Of the 5 largest reported holders, 1 opened a new position in BTMD, 2 reduced their positions and 2 held their positions unchanged during the quarter. Every reported holder and its change is on the SentiSense ownership page for BTMD.
Every reported institutional holder, plus insider and congressional trades in BTMD, on SentiSense.